Literature DB >> 22130565

Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury.

Hannah M Tuinstra1, Misael O Aviles, Seungjin Shin, Samantha J Holland, Marina L Zelivyanskaya, Alan G Fast, Sarah Y Ko, Daniel J Margul, Anne K Bartels, Ryan M Boehler, Brian J Cummings, Aileen J Anderson, Lonnie D Shea.   

Abstract

Therapeutic strategies following spinal cord injury must address the multiple barriers that limit regeneration. Multiple channel bridges have been developed that stabilize the injury following implantation and provide physical guidance for regenerating axons. These bridges have now been employed as a vehicle for localized delivery of lentivirus. Implantation of lentivirus loaded multiple channel bridges produced transgene expression that persisted for at least 4 weeks. Expression was maximal at the implant at the earliest time point, and decreased with increasing time of implantation, as well as rostral and caudal to the bridge. Immunohistochemical staining indicated transduction of macrophages, Schwann cells, fibroblasts, and astrocytes within the bridge and adjacent tissue. Subsequently, the delivery of lentivirus encoding the neurotrophic factors NT-3 or BDNF significantly increased the extent of axonal growth into the bridge relative to empty scaffolds. In addition to promoting axon growth, the induced expression of neurotrophic factors led to myelination of axons within the channels of the bridge, where the number of myelinated axons was significantly enhanced relative to control. Combining gene delivery with biomaterials to provide physical guidance and create a permissive environment can provide a platform to enhance axonal growth and promote regeneration.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130565      PMCID: PMC3237872          DOI: 10.1016/j.biomaterials.2011.11.002

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  48 in total

1.  Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord.

Authors:  Karim Fouad; Lisa Schnell; Mary B Bunge; Martin E Schwab; Thomas Liebscher; Damien D Pearse
Journal:  J Neurosci       Date:  2005-02-02       Impact factor: 6.167

2.  Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury.

Authors:  Sara J Taylor; Ephron S Rosenzweig; John W McDonald; Shelly E Sakiyama-Elbert
Journal:  J Control Release       Date:  2006-06-22       Impact factor: 9.776

3.  In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury.

Authors:  Anjana Jain; Young-Tae Kim; Robert J McKeon; Ravi V Bellamkonda
Journal:  Biomaterials       Date:  2005-08-15       Impact factor: 12.479

4.  Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice.

Authors:  Brian J Cummings; Nobuko Uchida; Stanley J Tamaki; Desirée L Salazar; Mitra Hooshmand; Robert Summers; Fred H Gage; Aileen J Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord.

Authors:  Christelle Girard; Alexis-Pierre Bemelmans; Noëlle Dufour; Jacques Mallet; Corinne Bachelin; Brahim Nait-Oumesmar; Anne Baron-Van Evercooren; François Lachapelle
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

6.  Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats.

Authors:  S David; A J Aguayo
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

7.  Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1.

Authors:  N Weidner; A Blesch; R J Grill; M H Tuszynski
Journal:  J Comp Neurol       Date:  1999-11-01       Impact factor: 3.215

8.  Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function.

Authors:  Y Liu; D Kim; B T Himes; S Y Chow; T Schallert; M Murray; A Tessler; I Fischer
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

9.  Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival.

Authors:  Caitlin E Hill; Lawrence D F Moon; Patrick M Wood; Mary Bartlett Bunge
Journal:  Glia       Date:  2006-02       Impact factor: 7.452

10.  Characterization of non-neuronal elements within fibronectin mats implanted into the damaged adult rat spinal cord.

Authors:  V R King; J B Phillips; H Hunt-Grubbe; R Brown; J V Priestley
Journal:  Biomaterials       Date:  2005-08-18       Impact factor: 12.479

View more
  47 in total

1.  Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.

Authors:  Aline M Thomas; Jaime L Palma; Lonnie D Shea
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

2.  Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration.

Authors:  Hannah M Tuinstra; Daniel J Margul; Ashley G Goodman; Ryan M Boehler; Samantha J Holland; Marina L Zelivyanskaya; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-12-11       Impact factor: 3.845

Review 3.  Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.

Authors:  Corey J Bishop; Jayoung Kim; Jordan J Green
Journal:  Ann Biomed Eng       Date:  2013-10-30       Impact factor: 3.934

4.  Spinal Progenitor-Laden Bridges Support Earlier Axon Regeneration Following Spinal Cord Injury.

Authors:  Courtney M Dumont; Mary K Munsell; Mitchell A Carlson; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2018-10-19       Impact factor: 3.845

5.  Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors.

Authors:  Aline M Thomas; Andrew J Gomez; Jaime L Palma; Woon Teck Yap; Lonnie D Shea
Journal:  Biomaterials       Date:  2014-07-11       Impact factor: 12.479

Review 6.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

7.  Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model.

Authors:  Dominique R Smith; Courtney M Dumont; Jonghyuck Park; Andrew J Ciciriello; Amina Guo; Ravindra Tatineni; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2020-02-25       Impact factor: 3.845

Review 8.  Recent advances in nanotherapeutic strategies for spinal cord injury repair.

Authors:  Young Hye Song; Nikunj K Agrawal; Jonathan M Griffin; Christine E Schmidt
Journal:  Adv Drug Deliv Rev       Date:  2018-12-22       Impact factor: 15.470

Review 9.  Hydrogels for lentiviral gene delivery.

Authors:  Stephanie K Seidlits; Robert Michael Gower; Jaclyn A Shepard; Lonnie D Shea
Journal:  Expert Opin Drug Deliv       Date:  2013-01-25       Impact factor: 6.648

Review 10.  Matrix-based gene delivery for tissue repair.

Authors:  Cynthia Cam; Tatiana Segura
Journal:  Curr Opin Biotechnol       Date:  2013-05-14       Impact factor: 9.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.